337 related articles for article (PubMed ID: 30886529)
1. Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
Lambertini M; Richard F; Nguyen B; Viglietti G; Villarreal-Garza C
Clin Med Insights Reprod Health; 2019; 13():1179558119828393. PubMed ID: 30886529
[TBL] [Abstract][Full Text] [Related]
2. Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review.
Poggio F; Lambertini M; Bighin C; Conte B; Blondeaux E; D'Alonzo A; Dellepiane C; Buzzatti G; Molinelli C; Boccardo F; Del Mastro L
Clin Med Insights Reprod Health; 2019; 13():1179558119864584. PubMed ID: 31391786
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of ovarian function preservation with GnRH agonist during chemotherapy in premenopausal women with early breast cancer.
Huang Y; Huang X; Huang X; Lin S; Luo S; Gu D; Weng X; Xu X
Hum Reprod; 2023 Jun; 38(6):1099-1110. PubMed ID: 37075316
[TBL] [Abstract][Full Text] [Related]
4. The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast Cancer.
Blondeaux E; Massarotti C; Fontana V; Poggio F; Arecco L; Fregatti P; Bighin C; Giannubilo I; Ruelle T; Razeti MG; Boni L; Anserini P; Del Mastro L; Lambertini M
Front Oncol; 2021; 11():690320. PubMed ID: 34150661
[TBL] [Abstract][Full Text] [Related]
5. How to Protect Ovarian Function before and during Chemotherapy?
Arecco L; Ruelle T; Martelli V; Boutros A; Latocca MM; Spinaci S; Marrocco C; Massarotti C; Lambertini M
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575299
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.
Lambertini M; Moore HCF; Leonard RCF; Loibl S; Munster P; Bruzzone M; Boni L; Unger JM; Anderson RA; Mehta K; Minton S; Poggio F; Albain KS; Adamson DJA; Gerber B; Cripps A; Bertelli G; Seiler S; Ceppi M; Partridge AH; Del Mastro L
J Clin Oncol; 2018 Jul; 36(19):1981-1990. PubMed ID: 29718793
[TBL] [Abstract][Full Text] [Related]
8. Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical application.
Lambertini M; Horicks F; Del Mastro L; Partridge AH; Demeestere I
Cancer Treat Rev; 2019 Jan; 72():65-77. PubMed ID: 30530271
[TBL] [Abstract][Full Text] [Related]
9. Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.
Lambertini M; Fontana V; Massarotti C; Poggio F; Dellepiane C; Iacono G; Abate A; Miglietta L; Ferreccio C; Pescio MC; Conte B; Blondeaux E; Bighin C; D'Alonzo A; Vaglica M; Zanardi E; Boccardo F; Ballestrero A; Anserini P; Del Mastro L
Breast; 2018 Oct; 41():51-56. PubMed ID: 30007268
[TBL] [Abstract][Full Text] [Related]
10. The role of gonadotropin-releasing hormone agonists in female fertility preservation.
Lee JH; Choi YS
Clin Exp Reprod Med; 2021 Mar; 48(1):11-26. PubMed ID: 33648041
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.
Blumenfeld Z; Zur H; Dann EJ
Oncologist; 2015 Nov; 20(11):1283-9. PubMed ID: 26463871
[TBL] [Abstract][Full Text] [Related]
12. The risk of menopausal symptoms in premenopausal breast cancer patients and current pharmacological prevention strategies.
Lei YY; Yeo W
Expert Opin Drug Saf; 2021 Oct; 20(10):1163-1175. PubMed ID: 33951990
[No Abstract] [Full Text] [Related]
13. Controversies Regarding Ovarian Suppression and Infertility in Early Stage Breast Cancer.
Durrani S; Heena H
Cancer Manag Res; 2020; 12():813-817. PubMed ID: 32104064
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
[TBL] [Abstract][Full Text] [Related]
15. Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review.
Ingold C; Navarro PA; de Oliveira R; Barbosa CP; Bedoschi G
Ther Adv Reprod Health; 2023; 17():26334941231196545. PubMed ID: 37674690
[TBL] [Abstract][Full Text] [Related]
16. Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.
Lambertini M; Del Mastro L; Viglietti G; Pondé NF; Solinas C; de Azambuja E
Curr Treat Options Oncol; 2017 Jan; 18(1):4. PubMed ID: 28185173
[TBL] [Abstract][Full Text] [Related]
17. Effects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function Against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women With Breast Cancer in China: A Randomized Clinical Trial.
Zong X; Yu Y; Yang H; Chen W; Ding X; Liu S; Li X; Chen X; Jiang C; Xia X; Huang R; Zhu M; Hu J; Liang C
JAMA Oncol; 2022 Feb; 8(2):252-258. PubMed ID: 34967844
[TBL] [Abstract][Full Text] [Related]
18. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.
Clowse ME; Behera MA; Anders CK; Copland S; Coffman CJ; Leppert PC; Bastian LA
J Womens Health (Larchmt); 2009 Mar; 18(3):311-9. PubMed ID: 19281314
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients.
Lambertini M; Boni L; Michelotti A; Magnolfi E; Cogoni AA; Mosconi AM; Giordano M; Garrone O; Arpino G; Poggio F; Cinacchi P; Bighin C; Fregatti P; Pronzato P; Blondeaux E; Del Mastro L;
J Natl Cancer Inst; 2022 Mar; 114(3):400-408. PubMed ID: 34850043
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients.
Conte B; Del Mastro L
Minerva Ginecol; 2017 Aug; 69(4):350-356. PubMed ID: 28398024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
